The global enzyme-linked immunosorbent assay (ELISA) testing market size is expected to reach US$ 4.02 billion by 2030 from US$ 1.63 billion in 2020 and is expected to grow at an impressive double-digit rate of 6.4% from 2021 to 2030.
The study includes drivers and restraints of this market. The study provides an analysis of the global enzyme-linked immunosorbent assay (ELISA) testing Market for the period 2017-2030, wherein 2021 to 2030 is the forecast period and 2020 is considered as the base year.
Crucial factors accountable for market growth are:
- Growing incidence of infectious disorders such as hepatitis, dengue, and AIDS
- Increasing prevalence of neurological disorders
- Growing geriatric population
- High research and development expenditure of major players
- Growing per capita healthcare spending
- Growing incidence of non-communicable diseases
- Emergence of cost-effective technologies
Download the Sample Pages for More Understanding@ https://www.precedenceresearch.com/sample/1260
The analyst presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on enzyme-linked immunosorbent assay (Elisa) testing market covers the following areas:
• Enzyme-linked immunosorbent assay (Elisa) testing market sizing
• Enzyme-linked immunosorbent assay (Elisa) testing market forecast
• Enzyme-linked immunosorbent assay (Elisa) testing market industry analysis
| Report Highlights | Details |
| Market Size | USD 4.02 Billion by 2030 |
| Growth Rate | CAGR of 6.4% From 2021 to 2030 |
| Base Year | 2020 |
| Forecast Period | 2021 to 2030 |
| Segments Covered | Test, Application, Region |
| Companies Mentioned | Thermo Fisher Scientific, Inc., ALPCO, Bio-Rad Laboratories, Inc., BD, BioMérieux SA, Ortho Clinical Diagnostics, R&D Systems, Inc., ZEUS Scientific, Inc. |
Why should you invest in this report?
If you are aiming to enter the global enzyme-linked immunosorbent assay (ELISA) testing market, this report is a comprehensive guide that provides crystal clear insights into this niche market. All the major application areas for enzyme-linked immunosorbent assay (ELISA) testing are covered in this report and information is given on the important regions of the world where this market is likely to boom during the forecast period of 2021-2030, so that you can plan your strategies to enter this market accordingly.
Besides, through this report, you can have a complete grasp of the level of competition you will be facing in this hugely competitive market and if you are an established player in this market already, this report will help you gauge the strategies that your competitors have adopted to stay as market leaders in this market. For new entrants to this market, the voluminous data provided in this report is invaluable.
Major Two Enzyme-linked Immunosorbent Assay (ELISA) Testing Market Participants:
Bio-Rad Laboratories Inc.
In April 2020, the company announced the acquisition of Celsee Inc., a company that offers consumables and instruments for isolation, detection, and analysis of single cells. In April 2020, the company announced the launch of a blood-based immunoassay kit to perform serology assay to identify antibodies for the coronavirus SARS-CoV-2.
Becton, Dickinson and Co.
In February 2020, the company announced a long-term strategic partnership agreement with Babson Diagnostics to bring laboratory-quality, small-volume blood collection to retail pharmacies. In November 2019, the company launched enhanced antimicrobial stewardship analytics capabilities.
Leading competitors contending in global enzyme-linked immunosorbent assay (ELISA) testing market are as follows:
- Thermo Fisher Scientific, Inc.
- American Laboratory Products Company (ALPCO)
- BioMérieux SA
- Ortho Clinical Diagnostics
- R&D Systems, Inc.
- ZEUS Scientific, Inc.
Key Market Developments:
On November, 2019, ALPCO announced the official launch of its STELLUX Chemi Glucagon ELISA. The new chemiluminescence ELISA features increased analytical specificity and a broad range to accurately quantify glucagon levels between 0.86 and 143.7 pmol/L (3-500 pg/mL) in human and rodent samples.
Major Market Segments Covered:
By Test Type
- Sandwich ELISA
- Indirect ELISA
- Multiple and Portable ELISA
- Competitive ELISA
- Others
By Application
- Immunology
- Inflammation
- Infectious diseases
- Cancer
- Protein quantification
- Other Applications
Regional Analysis:
The geographical analysis of the global enzyme-linked immunosorbent assay (ELISA) testing market has been done for North America, Europe, Asia-Pacific, and the Rest of the World.
The North American market is again segmented into the US, Canada, and Mexico. Coming to the European market, it can be segmented further into the UK, Germany, France, Italy, Spain, and the rest. Coming to the Asia-Pacific, the global enzyme-linked immunosorbent assay (ELISA) testing Market is segmented into China, India, Japan, and Rest of Asia Pacific. Among others, the market is segmented into the Middle East and Africa, (GCC, North Africa, South Africa and Rest of the Middle East & Africa).
Key Questions Answered by the Report:
- What will be the size of the global enzyme-linked immunosorbent assay (ELISA) testing market in 2030?
- What is the expected CAGR for the enzyme-linked immunosorbent assay (ELISA) testing market between 2021 and 2030?
- Which are the top players active in this global market?
- What are the key drivers of this global market?
- How will the market situation change in the coming years?
- Which region held the highest market share in this global market?
- What are the common business tactics adopted by players?
- What is the growth outlook of the global enzyme-linked immunosorbent assay (ELISA) testing market?
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Enzyme-Linked Immunosorbent Assay (ELISA) Testing Market, By Test Type
7.1. Enzyme-Linked Immunosorbent Assay (ELISA) Testing Market, by Test Type, 2021-2030
7.1.1. Sandwich ELISA
7.1.1.1. Market Revenue and Forecast (2017-2030)
7.1.2. Indirect ELISA
7.1.2.1. Market Revenue and Forecast (2017-2030)
7.1.3. Multiple and Portable ELISA
7.1.3.1. Market Revenue and Forecast (2017-2030)
7.1.4. Competitive ELISA
7.1.4.1. Market Revenue and Forecast (2017-2030)
7.1.5. Others
7.1.5.1. Market Revenue and Forecast (2017-2030)
Chapter 8. Global Enzyme-Linked Immunosorbent Assay (ELISA) Testing Market, By Application
8.1. Enzyme-Linked Immunosorbent Assay (ELISA) Testing Market, by Application, 2021-2030
8.1.1. Immunology
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Inflammation
8.1.2.1. Market Revenue and Forecast (2017-2030)
8.1.3. Infectious diseases
8.1.3.1. Market Revenue and Forecast (2017-2030)
8.1.4. Cancer
8.1.4.1. Market Revenue and Forecast (2017-2030)
8.1.5. Protein quantification
8.1.5.1. Market Revenue and Forecast (2017-2030)
8.1.6. Other Applications
8.1.6.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Enzyme-Linked Immunosorbent Assay (ELISA) Testing Market, Regional Estimates and Trend Forecast
9.1. North America
9.1.1. Market Revenue and Forecast, by Test (2017-2030)
9.1.2. Market Revenue and Forecast, by Application (2017-2030)
9.1.3. U.S.
9.1.3.1. Market Revenue and Forecast, by Test (2017-2030)
9.1.3.2. Market Revenue and Forecast, by Application (2017-2030)
9.1.4. Rest of North America
9.1.4.1. Market Revenue and Forecast, by Test (2017-2030)
9.1.4.2. Market Revenue and Forecast, by Application (2017-2030)
9.2. Europe
9.2.1. Market Revenue and Forecast, by Test (2017-2030)
9.2.2. Market Revenue and Forecast, by Application (2017-2030)
9.2.3. UK
9.2.3.1. Market Revenue and Forecast, by Test (2017-2030)
9.2.3.2. Market Revenue and Forecast, by Application (2017-2030)
9.2.4. Germany
9.2.4.1. Market Revenue and Forecast, by Test (2017-2030)
9.2.4.2. Market Revenue and Forecast, by Application (2017-2030)
9.2.5. France
9.2.5.1. Market Revenue and Forecast, by Test (2017-2030)
9.2.5.2. Market Revenue and Forecast, by Application (2017-2030)
9.2.6. Rest of Europe
9.2.6.1. Market Revenue and Forecast, by Test (2017-2030)
9.2.6.2. Market Revenue and Forecast, by Application (2017-2030)
9.3. APAC
9.3.1. Market Revenue and Forecast, by Test (2017-2030)
9.3.2. Market Revenue and Forecast, by Application (2017-2030)
9.3.3. India
9.3.3.1. Market Revenue and Forecast, by Test (2017-2030)
9.3.3.2. Market Revenue and Forecast, by Application (2017-2030)
9.3.4. China
9.3.4.1. Market Revenue and Forecast, by Test (2017-2030)
9.3.4.2. Market Revenue and Forecast, by Application (2017-2030)
9.3.5. Japan
9.3.5.1. Market Revenue and Forecast, by Test (2017-2030)
9.3.5.2. Market Revenue and Forecast, by Application (2017-2030)
9.3.6. Rest of APAC
9.3.6.1. Market Revenue and Forecast, by Test (2017-2030)
9.3.6.2. Market Revenue and Forecast, by Application (2017-2030)
9.4. MEA
9.4.1. Market Revenue and Forecast, by Test (2017-2030)
9.4.2. Market Revenue and Forecast, by Application (2017-2030)
9.4.3. GCC
9.4.3.1. Market Revenue and Forecast, by Test (2017-2030)
9.4.3.2. Market Revenue and Forecast, by Application (2017-2030)
9.4.4. North Africa
9.4.4.1. Market Revenue and Forecast, by Test (2017-2030)
9.4.4.2. Market Revenue and Forecast, by Application (2017-2030)
9.4.5. South Africa
9.4.5.1. Market Revenue and Forecast, by Test (2017-2030)
9.4.5.2. Market Revenue and Forecast, by Application (2017-2030)
9.4.6. Rest of MEA
9.4.6.1. Market Revenue and Forecast, by Test (2017-2030)
9.4.6.2. Market Revenue and Forecast, by Application (2017-2030)
9.5. Latin America
9.5.1. Market Revenue and Forecast, by Test (2017-2030)
9.5.2. Market Revenue and Forecast, by Application (2017-2030)
9.5.3. Brazil
9.5.3.1. Market Revenue and Forecast, by Test (2017-2030)
9.5.3.2. Market Revenue and Forecast, by Application (2017-2030)
9.5.4. Rest of LATAM
9.5.4.1. Market Revenue and Forecast, by Test (2017-2030)
9.5.4.2. Market Revenue and Forecast, by Application (2017-2030)
Chapter 10. Company Profiles
10.1. Thermo Fisher Scientific, Inc.
10.1.1. Company Overview
10.1.2. Product Offerings
10.1.3. Financial Performance
10.1.4. Recent Initiatives
10.2. American Laboratory Products Company (ALPCO)
10.2.1. Company Overview
10.2.2. Product Offerings
10.2.3. Financial Performance
10.2.4. Recent Initiatives
10.3. Bio-Rad Laboratories, Inc.
10.3.1. Company Overview
10.3.2. Product Offerings
10.3.3. Financial Performance
10.3.4. Recent Initiatives
10.4. BD
10.4.1. Company Overview
10.4.2. Product Offerings
10.4.3. Financial Performance
10.4.4. Recent Initiatives
10.5. BioMérieux SA
10.5.1. Company Overview
10.5.2. Product Offerings
10.5.3. Financial Performance
10.5.4. Recent Initiatives
10.6. Ortho Clinical Diagnostics
10.6.1. Company Overview
10.6.2. Product Offerings
10.6.3. Financial Performance
10.6.4. Recent Initiatives
10.7. R&D Systems, Inc.
10.7.1. Company Overview
10.7.2. Product Offerings
10.7.3. Financial Performance
10.7.4. Recent Initiatives
10.8. ZEUS Scientific, Inc.
10.8.1. Company Overview
10.8.2. Product Offerings
10.8.3. Financial Performance
10.8.4. Recent Initiatives
Chapter 11. Research Methodology
11.1. Primary Research
11.2. Secondary Research
11.3. Assumptions
Chapter 12. Appendix
12.1. About Us
12.2. Glossary of Terms
Buy this Premium Research Report@ https://www.precedenceresearch.com/checkout/1260
About Us:
Precedence Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semi-conductors, chemicals, automotive, and among different ventures present globally.
Contact Us:
Mr. Alex
Sales Manager
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
0 Comments